

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications. Among its major competitors, Athersys is ranked in 9th place for NPS while Denali Therapeutics is 1st, and Biogen is 2nd.Their current market cap is $464.59M